CVS Health stock is trading -25.62% below its average target price of $90.16 after marking a 1.2% during today's morning session. Analysts are giving the large-cap Pharmaceutical Retail company an average rating of buy and target prices ranging from $76.0 to $110.0 per share.
CVS Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.1%. The stock's short ratio is 1.96. The company's insiders own 0.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 79.9%. In conclusion, we believe there is mixed market sentiment regarding CVS Health.
Institutions Invested in CVS Health
|2023-06-30||Vanguard Group Inc||9%||116,676,882||$7,824,351,422|
|2023-06-30||State Street Corporation||4%||55,877,387||$3,747,137,435|
|2023-06-30||Capital World Investors||2%||30,490,802||$2,044,713,107|
|2023-06-30||Geode Capital Management, LLC||2%||23,325,287||$1,564,193,689|
|2023-06-30||Bank of America Corporation||1%||16,551,119||$1,109,917,999|
|2023-06-30||Dodge & Cox Inc||1%||16,024,422||$1,074,597,700|